FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 119_S_2620.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2025-07-31.
What are the main provisions?
Key points include:
- Pharmaceutical companies will only be able to select one patent for protection against generic competition, shortening the wait for cheaper alternatives.
- The changes aim to prevent practices that artificially prolong drug monopolies, potentially leading to lower prices and more choices for patients.
What is the specific legal status?
The current status is Introduced.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Durbin, Richard J. [D-IL].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.